Perioperative risk and management in patients with pulmonary hypertension

Chest

Volumn 144, Issue 1, 2013, Pages 329-340

  Minai, Omar A ^a   Yared, Jean Pierre ^a   Kaw, Roop ^a   Subramaniam, Kathirvel ^b   Hill, Nicholas S ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; FENTANYL; GLYCERYL TRINITRATE; ILOPROST; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NITROUS OXIDE; PROPOFOL; PROSTACYCLIN; SILDENAFIL; SUFENTANIL; THIOPENTAL;

ANESTHESIOLOGICAL PROCEDURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DEATH; DISEASE SEVERITY; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PRELOAD; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HUMAN; HYPERCAPNIA; HYPOTENSION; HYPOXIA; LUNG ARTERY PRESSURE; LUNG VENTILATION; MONITORING; OXYGENATION; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK;

EID: 84880071049     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1752     Document Type: Review

References (73)

1. McLaughlin VV, Archer SL, Badesch DB, et al; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009; 53 (17): 1573-1619.
2. Minai OA, Venkateshiah SB, Arroliga AC. Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med. 2006; 70 (4): 239-243.
3. Kaw R, Sharma P, Minai OA. What risks does a history of pulmonary hypertension present for patients undergoing non cardiac surgery? Cleve Clin J Med. 2007; 74 (suppl 1): S20-S21.
4. Kaw R, Pasupuleti V, Deshpande A, Hamieh T, Walker E, Minai OA. Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med. 2011; 105 (4): 619-624.
5. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative mor bidity and mortality. J Am Coll Cardiol. 2005; 45 (10): 1691-1699.
6. Diaz-Guzman E, Vadi S, Minai OA, Gildea TR, Mehta AC. Safety of diagnostic bronchoscopy in patients with pulmonary hypertension. Respiration. 2009; 77 (3): 292-297.
7. Kuralay E, Demírkiliç U, Oz BS, Cíngöz F, Tatar H. Primary pulmonary hypertension and coronary artery bypass surgery. J Card Surg. 2002; 17 (1): 79-80.
8. Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg. 1999; 89 (4): 814-822.
9. Hill NS, Roberts KR, Preston IR. Postoperative pulmonary hypertension: etiology and treatment of a dangerous complication. Respir Care. 2009; 54 (7): 958-968.
10. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology. 2003; 99 (6): 1415-1432.
11. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005; 128 (3): 1836-1852.
12. Subramaniam K, Yared J-P. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth. 2007; 11 (2): 119-136.
13. Vlahakes GJ. Management of pulmonary hypertension and right ventricular failure: another step forward. Ann Thorac Surg. 1996; 61 (4): 1051-1052.
14. McIntyre KM, Sasahara AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest. 1974; 65 (5): 534-543.
15. Rudolph AM, Yuan S. Response of the pulmonary vasculature to hypoxia and H 1 ion concentration changes. J Clin Invest. 1966; 45 (3): 399-411.
16. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000; 6 (4): 443-450.
17. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999; 15 (6): 816-822.
18. Beck JR, Mongero LB, Kroslowitz RM, et al. Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery. Perfusion. 1999; 14 (1): 37-42.
19. Robitaille A, Denault AY, Couture P, et al. Importance of relative pulmonary hypertension in cardiac surgery: the mean systemic-to-pulmonary artery pressure ratio. J Cardiothorac Vasc Anesth. 2006; 20 (3): 331-339.
20. Cesnjevar RA, Feyrer R, Walther F, Mahmoud FO, Lindemann Y, von der Emde J. High-risk mitral valve replacement in severe pulmonary hypertension - 30 years experience. Eur J Cardiothorac Surg. 1998; 13 (4): 344-351.
21. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988; 7 (5): 331-336.
22. Tsai FC, Marelli D, Bresson J, et al. Recent trends in early outcome of adult patients after heart transplantation: a singleinstitution review of 251 transplants using standard donor organs. Am J Transplant. 2002; 2 (6): 539-545.
23. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993; 126 (4): 896-904.
24. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010; 122 (2): 173-183.
25. Balzer DT, Kort HW, Day RW, et al. Inhaled nitric oxide as a preoperative test (INOP Test I): the INOP Test Study Group. Circulation. 2002; 106 (12 suppl 1): 176-181.
26. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant. 2000; 19 (10): 909-931.
27. Koul B, Wollmer P, Willen H, Kugelberg J, Steen S. Venoarterial extracorporeal membrane oxygenation - how safe is it? Evaluation with a new experimental model. J Thorac Cardiovasc Surg. 1992; 104 (3): 579-584.
28. Hashimoto K, Miyamoto H, Suzuki K, et al. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg. 1992; 104 (3): 666-673.
29. Knothe C, Boldt J, Zickmann B, Ballesteros M, Dapper F, Hempelmann G. Endothelin plasma levels in old and young patients during open heart surgery: correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharmacol. 1992; 20 (4): 664-670.
30. Morita K, Ihnken K, Buckberg GD, Sherman MP, Ignarro LJ. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg. 1996; 61 (6): 1775-1780.
31. Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth. 2007; 99 (2): 184-190.
32. Price LC, Montani D, Jaïs X, et al. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J. 2010; 35 (6): 1294-1302.
33. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120( 21): e169-e276.
34. Ishikawa S, Ohtaki A, Takahashi T, et al. Lung impairment following cardiac surgery in patients with pulmonary hypertension. J Cardiovasc Surg (Torino). 2002; 43 (1): 7-10.
35. Rodriguez RM, Pearl RG. Pulmonary hypertension and major surgery. Anesth Analg. 1998; 87 (4): 812-815.
36. Roessler P, Lambert TF. Anaesthesia for caesarean section in the presence of primary pulmonary hypertension. Anaesth Intensive Care. 1986; 14 (3): 317-320.
37. Armstrong P. Thoracic epidural anaesthesia and primary pulmonary hypertension. Anaesthesia. 1992; 47 (6): 496-499.
38. Slomka F, Salmeron S, Zetlaoui P, Cohen H, Simonneau G, Samii K. Primary pulmonary hypertension and pregnancy: anesthetic management for delivery. Anesthesiology. 1988; 69 (6): 959-961.
39. Ivy DD, Griebel JL, Kinsella JP, Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr. 1998; 133 (3): 453-456.
40. Sarkar M, Laussen PC, Zurakowski D, Shukla A, Kussman B, Odegard KC. Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients. Anesth Analg. 2005; 101 (3): 645-650.
41. Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992; 76 (5): 725-733.
42. Williams GD, Philip BM, Chu LF, et al. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg. 2007; 105( 6): 1578-1584.
43. Tanita T, Tomoyasu M, Deguchi H, Mizuno M, Kawazoe K. Review of preoperative functional evaluation for lung resection using the right ventricular hemodynamic functions. Ann Thorac Cardiovasc Surg. 2004; 10 (6): 333-339.
44. MacKnight B, Martine EA, Simo BA. Anesthetic management of patients with pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2008; 12 (2): 91-96.
45. Martin JT, Tautz TJ, Antognini JF. Safety of regional anesthesia in Eisenmenger's syndrome. Reg Anesth Pain Med. 2002; 27 (5): 509-513.
46. Ciofolo MJ, Reiz S. Circulatory effects of volatile anesthetic agents. Minerva Anestesiol. 1999; 65 (5): 232-238.
47. Pagel PS, Fu JL, Damask MC, et al. Desflurane and isoflurane produce similar alterations in systemic and pulmonary hemodynamics and arterial oxygenation in patients undergoing one-lung ventilation during thoracotomy. Anesth Analg. 1998; 87 (4): 800-807.
48. Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology. 1982; 57 (1): 9-13.
49. Myles PS, Chan MT, Kaye DM, et al. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology. 2008; 109 (4): 657-663.
50. Fox C, Kalarickal PL, Yarborough MJ, Jin JY. Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery. Curr Opin Anaesthesiol. 2008; 21 (4): 467-472.
51. Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology. 1999; 91 (1): 307-310.
52. Ivy DD, Kinsella JP, Ziegle JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after nitric oxide withdrawal in post operative congenital heart disease. J Thorac Cardiovasc Surg. 1998; 115 (4): 875-882.
53. Braun EB, Palin CA, Hogue CW. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. Anesth Analg. 2004; 99 (1): 36-37.
54. Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004; 109 (25): 3106-3111.
55. Bhorade S, Christenson J, O'connor M, Lavoie A, Pohlman A, Hall JB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med. 1999; 159 (2): 571-579.
56. Fattouch K, Sbraga F, Bianco G, et al. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg. 2005; 20 (2): 171-176.
57. Solina A, Papp D, Ginsberg S, et al. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth. 2000; 14 (1): 12-17.
58. Rocca GD, Coccia C, Pompei L, et al. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin. J Cardiothorac Vasc Anesth. 2001; 15 (2): 224-227.
59. De Wet CJ, Affleck DG, Jacobsohn E, et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg. 2004; 127 (4): 1058-1067.
60. Haché M, Denault AY, Bélisle S, et al. Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit. Can J Anaesth. 2001; 48 (9): 924-929.
61. Schroeder RA, Wood GL, Plotkin JS, Kuo PC. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure. Anesth Analg. 2000; 91 (2): 291-295.
62. Winterhalter M, Simon A, Fischer S, et al. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth. 2008; 22 (3): 406-413.
63. Rex S, Schaelte G, Metzelder S, et al. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol Scand. 2008; 52 (1): 65-72.
64. Lee JE, Hillier SC, Knoderer CA. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med. 2008; 23 (5): 329-334.
65. De Santo LS, Mastroianni C, Romano G, et al. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients. Transplant Proc. 2008; 40 (6): 2015-2018.
66. Kleber FX, Bollmann T, Borst MM, et al. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study. J Clin Pharmacol. 2009; 49 (1): 109-115.
67. Kerbaul F, Rondelet B, Demester JP, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med. 2006; 34 (11): 2814-2819.
68. Ichinose F, Erana-Garcia J, Hromi J, et al. Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med. 2001; 29 (5): 1000-1005.
69. Sablotzki A, Starzmann W, Scheubel R, Grond S, Czeslick EG. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can J Anaesth. 2005; 52 (10): 1076-1082.
70. Lamarche Y, Perrault LP, Maltais S, Tétreault K, Lambert J, Denault AY. Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg. 2007; 31 (6): 1081-1087.
71. Wang H, Gong M, Zhou B, Dai A. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther. 2009; 26 (4): 462-468.
72. Mandal B, Kapoor PM, Chowdhury U, Kiran U, Choudhury M. Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension. Ann Card Anaesth. 2010; 13 (2): 138-144.
73. Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009; 54 (suppl 1): S67-S77.